Skip to main content

Table 5 Performance of participating HER2 testing centers.

From: Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

Hospital

Total

False-negative

False-positive

Concordance

Sensitivity

(%)

Specificity

(%)

1

144

3 (2.1%)

2 (1.4%)

139 (96.5%

98.6

97.9

2

266

0 (0.0%)

2 (0.8%)

264 (99.2%)

99.2

100.0

3

158

1 (0.6%)

0 (0.6%)

156 (98.7%)

100.0

99.4

4

181

2 (1.1%)

2 (1.1%)

177 (97.8%)

98.9

98.9

5

90

0 (0.0%)

5 (5.6%)

85 (94.4%)

94.4

100.0

6

169

1 (0.6%)

2 (1.2%)

166 (98.2%)

98.8

100.0

Total

1,008

7 (0.7%)

13 (1.3%)

988 (98.0%)

98.7

99.3

  1. HER2, human epidermal growth factor receptor 2.